UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000030646
Receipt No. R000034990
Official scientific title of the study Questionary survey of the percentage of inoculation of the influenza vaccine during the cancer duration of treatment
Date of disclosure of the study information 2018/01/01
Last modified on 2018/04/24 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Questionary survey of the percentage of inoculation of the influenza vaccine during the cancer duration of treatment
Title of the study (Brief title) Questionary survey of the percentage of inoculation of the influenza vaccine during the cancer duration of treatment
Region
Japan

Condition
Condition all cancers
Classification by specialty
Hematology and clinical oncology Radiology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To investigate that to took in influenza vaccine during cancer duration of treatment by questionary survey
Basic objectives2 Others
Basic objectives -Others To know how you took in influenza vaccine by questionary survey during cancer duration of treatment
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes We examine frequency how you took in influenza vaccine by questionary survey during cancer duration of treatment
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
10 years-old <=
Age-upper limit
90 years-old >
Gender Male and Female
Key inclusion criteria All patients with cancer
Key exclusion criteria The drug that influenza vaccine is contraindicated is given
Target sample size 30

Research contact person
Name of lead principal investigator Yuka Kunishima
Organization Asahi Univ. Murakami Memorial Hospital
Division name Dept. of Radiation Oncology
Address 3-23 Hashimoto-cho , Gifu, Gifu Pref.,Japan
TEL 058-2522-8001
Email kuni92.0805@gmail.com

Public contact
Name of contact person Osamu Tanaka
Organization Murakami Memorial hospital
Division name Dept.of Radiation Oncology
Address 3-32 Hashimoto-cho, Gifu, Gifu Pref.,Japan
TEL 058-252-8001
Homepage URL
Email c.bluered@gmail.com

Sponsor
Institute Asahi Univ. Murakami Memorial Hospital
Institute
Department

Funding Source
Organization Asahi Univ.
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 01 Month 01 Day

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 10 Month 01 Day
Anticipated trial start date
2017 Year 11 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information none

Management information
Registered date
2017 Year 12 Month 30 Day
Last modified on
2018 Year 04 Month 24 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034990